These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 1413076)

  • 21. Suppression of graft versus host reactivity by a single host-specific blood transfusion to prospective donors of hemopoietic cells.
    Knulst AC; Bril-Bazuin C; Ruizeveld de Winter JA; Benner R
    Transplant Proc; 1990 Aug; 22(4):1975-6. PubMed ID: 2389502
    [No Abstract]   [Full Text] [Related]  

  • 22. A class II antigen-specific T cell clone can suppress graft-versus-host reactivity in murine allogeneic bone marrow chimeras.
    Shih CC; Truitt RL
    Transplant Proc; 1987 Feb; 19(1 Pt 3):2664-7. PubMed ID: 2950639
    [No Abstract]   [Full Text] [Related]  

  • 23. [Effects of burn injury on the reactivity of spleen cells of mice of different genotypes during regional graft vs host reaction].
    Barsukov AN; Fedorov GN; Semenkov VF
    Biull Eksp Biol Med; 1990 Jun; 109(6):592-4. PubMed ID: 2397303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Retrovirus-mediated immunosuppression. II. FeLV-UV alters in vitro murine T lymphocyte behavior by reversibly impairing lymphokine secretion.
    Orosz CG; Zinn NE; Olsen RG; Mathes LE
    J Immunol; 1985 Jul; 135(1):583-90. PubMed ID: 2987350
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
    Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
    J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Attempts at standardization of lupus-like graft-vs-host disease: inadvertent repopulation by DBA/2 spleen cells of H-2-different nonirradiated F1 mice.
    Van Rappard-Van Der Veen FM; Radaszkiewicz T; Terraneo L; Gleichmann E
    J Immunol; 1983 Jun; 130(6):2693-701. PubMed ID: 6602176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Preferential activation of Th2 cells in chronic graft-versus-host reaction.
    De Wit D; Van Mechelen M; Zanin C; Doutrelepont JM; Velu T; Gérard C; Abramowicz D; Scheerlinck JP; De Baetselier P; Urbain J
    J Immunol; 1993 Jan; 150(2):361-6. PubMed ID: 8419469
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antagonistic effects of systemic interleukin 2 on immune Tcell-mediated graft-versus-leukemia reactivity.
    Schirrmacher V; Müerköster S; Umansky V
    Clin Cancer Res; 1998 Nov; 4(11):2635-45. PubMed ID: 9829726
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Differential expression of Fas and Fas ligand in acute and chronic graft-versus-host disease: up-regulation of Fas and Fas ligand requires CD8+ T cell activation and IFN-gamma production.
    Shustov A; Nguyen P; Finkelman F; Elkon KB; Via CS
    J Immunol; 1998 Sep; 161(6):2848-55. PubMed ID: 9743345
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malononitrilamides inhibit the development of various murine graft-vs-host diseases.
    Schorlemmer HU; Kurrle R; Bartlett RR
    Transplant Proc; 1996 Dec; 28(6):3043-7. PubMed ID: 8962181
    [No Abstract]   [Full Text] [Related]  

  • 31. Intraepithelial lymphocyte count and crypt hyperplasia measure the mucosal component of the graft-versus-host reaction in mouse small intestine.
    Mowat AM; Ferguson A
    Gastroenterology; 1982 Aug; 83(2):417-23. PubMed ID: 6979490
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunosuppressive effects of cyclosporin A on cloned T cells.
    Herold KC; Lancki DW; Moldwin RL; Fitch FW
    J Immunol; 1986 Feb; 136(4):1315-21. PubMed ID: 2935576
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vivo allogeneic effects: shift in the isotype profile of primary TI-2 responses in mice undergoing graft-vs-host reaction.
    Golding H; Rittenberg MB
    J Immunol; 1982 Nov; 129(5):1878-82. PubMed ID: 6749981
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of alloimmunization-induced T lymphocytes reactive against AKR leukemia in vitro and correlation with graft-vs-leukemia activity in vivo.
    Truitt RL; Shih CY; Lefever AV; Tempelis LD; Andreani M; Bortin MM
    J Immunol; 1983 Oct; 131(4):2050-8. PubMed ID: 6194224
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histamine as endogenous immunomodulator.
    Eckert R; Repke H
    Methods Find Exp Clin Pharmacol; 1986 Mar; 8(3):183-7. PubMed ID: 3487017
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possibility of three distinct and separable components to fatal graft-vs-host reaction.
    Okunewick JP; Meredith RF; Raikow RB; Buffo MJ; Jones DL
    Exp Hematol; 1982 Mar; 10(3):277-91. PubMed ID: 7040093
    [No Abstract]   [Full Text] [Related]  

  • 38. The influence of the age of donors and recipients on the regional graft-versus-host reaction in mice.
    Skowron-Cendrzak A; Kubera M; Bubak-Satora M; Godowicz W
    Arch Immunol Ther Exp (Warsz); 1991; 39(3):185-91. PubMed ID: 1810211
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adaptive phenomena in bone marrow transplantation.
    Goujet-Zalc C; Ilbery PL
    Exp Hematol; 1973; 1(1):3-10. PubMed ID: 4154047
    [No Abstract]   [Full Text] [Related]  

  • 40. Constitutive production of a unique lymphokine (IL 3) by the WEHI-3 cell line.
    Lee JC; Hapel AJ; Ihle JN
    J Immunol; 1982 Jun; 128(6):2393-8. PubMed ID: 6122701
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.